Pre-operative intravitreal bevacizumab for tractional retinal detachment secondary to proliferative diabetic retinopathy: the Alvaro Rodriguez lecture 2023
Abstract The treatment of proliferative diabetic retinopathy (PDR) has evolved significantly since the initial use of panretinal photocoagulation as a treatment in the 1950s.Vascular endothelial growth factor inhibitors have provided an effective alternative without the risk of peripheral vision loss.Despite this, the risk Essential Oil Roll-On of